Top

BMC Public Health

Published in:

01-12-2020 | River Blindness | Research article

Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia

Authors: Gebremedhin Gebrezgabiher, Zeleke Mekonnen, Delenasaw Yewhalaw, Asrat Hailu

Published in: BMC Public Health | Issue 1/2020

Abstract

Background

Control and elimination of onchocerciasis requires regular follow-up and evaluation of community directed treatment with ivermectin (CDTi) program implementation. This research was aimed to assess the epidemiological status of onchocerciasis in disease endemic communities of Asosa and Yeki districts of Ethiopia after 5 and 15 years of successive CDTi respectively, and to evaluate the decline in infection and morbidity burden.

Methods

A community-based cross-sectional study was conducted from August 2017 to January 2018 (i.e. within 2–7 months since the last treatment) using interview, physical and parasitological examinations. Pre-CDTi epidemiological data were obtained from studies conducted prior to the launch of CDTi.

Results

A total of 3002 individuals (1567 from Asosa and 1435 from Yeki) were included. No infection was detected from Yeki. In Asosa, the prevalence of infection was 1.6%. The geometric mean intensity of infection was 0.02 mf/mg of skin snip. The prevalence rates of dermatitis, depigmentation, nodule, and atrophy in Yeki were 33(2.3%), 57(4%), 37(2.6%) and 11(0.7%), respectively. The prevalence rates of papular dermatitis, depigmentation, palpable nodule, atrophy, and blindness in Asosa were 94(6%), 38(2.4%), 30(1.9%), 28(1.8%) and 2(0.1%), respectively. Five years of CDTi had significantly reduced prevalence and intensity of infection by 91.8% (p < 0.001) and 99.7% (p < 0.001), respectively. Moreover, CDTi reduced prevalence of papular dermatitis by 95.9% (p < 0.001), palpable nodule by 90.5% (p < 0.001), and atrophy by 30% (p = 0.6) in Yeki. Similarly, CDTi reduced prevalence of papular dermatitis by 88.6% (p < 0.001), depigmentation by 90.3% (p < 0.001), atrophy by 89.5% (p < 0.001), and blindness by 90% (p < 0.001) in Asosa.

Conclusions

Fifteen years of successive CDTi had brought the infection from high to zero in Yeki. However, thorough entomological and serological data need to be generated to ascertain whether complete interruption of parasite transmission has been attained, and for considerations of an evidence-based CDTi cessation. Five years of CDTi in Asosa has significantly reduced the infection and morbidity of onchocerciasis to very low level. We, hereby, recommend biannual CDTi to continue in Asosa and its surroundings until the infection transmission is fully interrupted.

Available only for authorised users

Taylor HR, Pacqué M, Muñoz B, Greene BM. Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science. 1990;250:116–8.PubMed

Schulz-Key H. Observations on the reproductive biology of Onchocerca volvulus. Acta Leiden. 1990;59:27–44.PubMed

Murdoch ME, Hay RJ, MacKenzie CD, Williams JF, Ghalib HW, Cousens S, et al. A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br J Dermatol. 1993;129:260–9.PubMed

Zein ZA. An appraisal of the epidemiologic situation of onchocerciasis in Ethiopia. Parassitologia. 1990;32:237–44.PubMed

Kloos H, Zein ZA. The ecology of health and disease in Ethiopia. Routledge; 2019.

Comen AP. Onchocerciasis in Kaffa Province of Ethiopia. Trop Geogr Med. 1967;9:231–46.

Iwamoto I, Tada I, Wonde T. Incidence and clinical manifestation of onchocerciasis in endemic foci of Hubabor Province, Ethiopia. Ethiopia Trop Med. 1973;15:36–45.

Ten Eyck DR. Comparison of biopsy and fluorescent antibody staining techniques for the detection and study of onchocerciasis in an ethiopian population. Am J Epidemiol. 1973;98:283–8.PubMed

De Sole G, Kloos H. Transmission patterns of onchocerciasis in Southwest Ethiopia. Parassitologia. 1976;18:53–65.PubMed

10.

Zein ZA. The epidemiology of onchocerciasis in northwestern Ethiopia. Trop Geogr Med. 1986;38:33–7.PubMed

11.

Taticheff S, Abebe M, Workneh W, Hana NG. Onchocerciasis: a prevalence study in Bebeka, Ethiopia. Trop Med Parasitol. 1987;38:279–82.PubMed

12.

Gundersen SG, Schmitt-Lechner A, Bjorvatn B. Onchocerciasis in the Blue Nile Valley of western Ethiopia. Trans R Soc Trop Med Hyg. 1988;82:122–7.PubMed

13.

Yeneneh H, Mengistu F, Ayele T. A multidisciplinary study of onchocerciasis in Bure area, Ethiopia. Ethiop Med J. 1989;27:121–8.PubMed

14.

Kloos H, Kello AB, Addus A. Onchocerciasis, malaria and trypanosomiasis in three resettlement schemes in western Ethiopia. Parassitologia. 1991;33:187–97.PubMed

15.

Jira C. Prevalence of onchocerciasis in Blue Nile valley of western Ethiopia. Indian J Public Heal. 1993;37:135–7.

16.

Taticheff S, Williams JF, Workneh W. Longitudinal study of onchocerciasis in Bebeka-Ethiopia. Ethiop Med J. 1993;31:191–200.PubMed

17.

Workneh W, Fletcher M, Olwit G. Onchocerciasis in field workers at baya farm, teppi coffee plantation project, southwestern Ethiopia: prevalence and impact on productivity. Acta Trop. 1993;54:89–97.PubMed

18.

Adugna N, Woldegiorgis M, Tilahwi D, Kebede A, Hadis M. Assessment of the infection rate of onchocerciasis in the resettled and indigenous communities of Asossa, Western Ethiopia. EJHD. 1996;10:89–95.

19.

Argaw H. Onchocerciasis among school children in Kafa, South West Ethiopia. Ethiop Med J. 1999;37:223–36.PubMed

20.

Adugna N, Woldegiorgis M, Tilahwi D, Kebede A, Hadis M. The epidemiology of onchocerciasis in the resettled and indigenous population in Pawe, western Ethiopia. Ethiop Med J. 1999;37:41–50.

21.

Mengistu G, Balcha F, Britton S. Clinical presentation of onchocerciasis among indigenous and migrant farmers in Southwest Ethiopia. East Afr Med J. 1999;76:635–8.PubMed

22.

Taye A, Gebre-Michael T, Taticheff S. Onchocerciasis in Gilgel Ghibe River valley Southwest Ethiopia. East Afr Med J. 2000;77:116–20.PubMed

23.

Hailu A, Balcha F, Birrie H, Berhe N, Aga A, Mengistu G, et al. Prevalence of onchocercal skin disease and infection among workers of coffee plantation farms in Teppi, southwestern Ethiopia. Ethiop Med J. 2002;40:259–69.PubMed

24.

Mengistu G, Balcha F, Britton S. Co-infection of Onchocerca volvulus and intestinal helminths in indigenous and migrant farmers in Southwest Ethiopia. Ethiop Med J. 2002;40:19–27.PubMed

25.

Dori GU, Belay T, Belete H, Panicker KN, Hailu A. Parasitological and clinico-epidemiological features of onchocerciasis in west Wellega, Ethiopia. J Parasit Dis. 2012;36:10–8.PubMed

26.

Katabarwa MN, Endeshaw T, Taye A, Tadesse Z, Frank RO. The disappearance of onchocerciasis without intervention in Tigray region in Northwest Ethiopia. Pathog Glob Heal. 2014;108:123.

27.

Dana D, Debalke S, Mekonnen Z, Kassahun W, Suleman S, Getahun K, et al. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma zone, southwestern Ethiopia. BMC Public Health. 2015;15:1–7.

28.

Feleke SM, Tadesse G, Mekete K, Tekle AH, Kebede A. Epidemiological mapping of human Onchocerciasis in transmission suspected districts of bale, Borena, and west Arsi zones of eastern Ethiopia. Interdiscip Perspect Infect Dis. 2016:1–5.

29.

Kifle B, Woldemichael K, Nigatu M. Prevalence of Onchocerciasis and associated factors among adults aged≥ 15 years in semen Bench District, bench Maji zone, Southwest Ethiopia: community based cross-sectional study. Adv Public Heal. 2019:1–9.

30.

Mengitsu B, Shafi O, Kebede B, Kebede F, Worku DT, Herero M, et al. Ethiopia and its steps to mobilize resources to achieve 2020 elimination and control goals for neglected tropical diseases webs joined can tie a lion. Int Health. 2015;8(Suppl 1):i34–52.

31.

Federal Ministry of Health. Second Edition of Ethiopia National Master Plan For Neglected Tropical Diseases. Addis Ababa: FMoH; 2016. p. 1–78.

32.

Federal Ministry of Health. Guidelines for Onchocerciasis Elimination in Ethiopia. Addis Ababa: FMoH; 2015. p. 1–90.

33.

Deribew A, Kebede B, Tessema GA, Adama YA, Misganaw A, Gebre T, et al. Mortality and disability-adjusted life-years (dalys) for common neglected tropical diseases in Ethiopia, 1990-2015: evidence from the global burden of disease study 2015. Ethiop Med J. 2017;55(Suppl 1):3–14.PubMedPubMedCentral

34.

Tekle AH, Zouré HGM, Noma M, Boussinesq M, Coffeng LE, Stolk WA, et al. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis control: epidemiological evaluation results. Infect Dis Poverty. 2016;5:1–25.

35.

Omondi EO, Nyabadza F, Smith RJ. Modelling the impact of mass administration of ivermectin in the treatment of onchocerciasis ( river blindness ). Cogent Math Stat. 2018;1:1–26.

36.

Federal Ministry of Health. National Master Plan for prevention control and elimination of Neglected Tropical Disease. Addis Ababa, Ethiopia. 2013;6–15.

37.

World Health Organization. Elimination of human onchocerciasis: progress report, 2018-2019. Wkly Epidemiol Rec. 2019;94A:513–24.

38.

Griswold E, Unnasch T, Eberhard M, Nwoke BEB, Morales Z, Muheki Tukahebwa E, et al. The role of national committees in eliminating onchocerciasis. Int Heal. 2018;10(suppl_1):i60–70.

39.

Meribo K, Kebede B, Feleke SM, Mengistu B, Mulugeta A, Sileshi M, et al. Review of Ethiopian Onchocerciasis elimination Programme. Ethiop Med J. 2017;55(Suppl 1):55–63.PubMedPubMedCentral

40.

Gebrezgabiher G, Mekonnen Z, Yewhalaw D, Hailu A. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa. Infect Dis Poverty. 2019;8:1–19.

41.

Lont YL, Coffeng LE, De Vlas SJ, Golden A, Santos TDL, Domingo GJ, et al. Modelling anti-Ov16 IgG4 antibody prevalence as an Indicator for evaluation and decision making in Onchocerciasis elimination Programmes. PLoS Negl Trop Dis. 2017;11(1):1–21.

42.

Dadzie Y, Amazigo UV, Boatin BA, Sékétéli A. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes. Infect Dis Poverty. 2018;7:1–11.

43.

Legesse M, Balcha F, Erko B. Status of onchocerciasis in Teppi area, southwestern Ethiopia, after four years of annual community-directed treatment with ivermectin. Ethiop J Heal Dev. 2010;24:51–6.

44.

QGIS Development team. QGIS Geographic Information System. Open Source Geospatial Foundation Project. 2020. http://qgis.osgeo.org.

45.

Katabarwa MN, Walsh F, Habomugisha P, Lakwo TL, Agunyo S, Oguttu DW, et al. Transmission of onchocerciasis in Wadelai focus of northwestern Uganda has been interrupted and the disease eliminated. J Parasitol Res. 2012;2012:1–7.

46.

Remme J, Ba O, Dadzie KY, Karam M. A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis control Programme in the Volta River basin area. Bull World Health Organ. 1986;64:667–81.PubMedPubMedCentral

47.

Frempong KK, Walker M, Cheke RA, Tetevi EJ, Gyan ET, Owusu EO, et al. Does increasing treatment frequency address suboptimal responses to ivermectin for the control and elimination of river blindness? Clin Infect Dis. 2016;62:1338–47.PubMedPubMedCentral

48.

Mas J, Ascaso C, Escaramis G, Abellana R, Duran E, Sima A, et al. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea. Trop Med Int Heal. 2006;11:1082–91.

49.

Osue HO, Inabo HI, Yakubu SE, Audu PA, Galadima M, Odama LE, et al. Impact of eighteen-year varied compliance to Onchocerciasis treatment with Ivermectin in sentinel Savannah agrarian communities in Kaduna state of Nigeria. ISRN Parasitol 2013;2013:1–10.

50.

Diawara L, Traoré MO, Badji A, Bissan Y, Doumbia K, Goita SF, et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis. 2009;3:1–15.

51.

Tekle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, Noma M, et al. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna state, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis control. Parasit Vectors. 2012;5:1–9.

52.

Higazi TB, Zarroug IMA, Mohamed HA, ElMubark WA, Deran TCM, Aziz N, et al. Interruption of Onchocerca volvulus transmission in the Abu Hamed focus, Sudan. Am J Trop Med Hyg. 2013;89:51–7.PubMedPubMedCentral

53.

Evans DS, Alphonsus K, Umaru J, Eigege A, Miri E, Mafuyai H, et al. Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in Central Nigeria: challenges in coordinating the stop MDA decision. PLoS Negl Trop Dis. 2014;8(9):e3113.PubMedPubMedCentral

54.

Ezeigbo OR, Nwoke BEB, Ugaka CN, Emuka EC. Impact assessment of repeated mass Ivermectin treatment on Onchocerciasis in Abia state. Nigeria JBAH. 2013;3:40–9.

55.

Vieira JC, Cooper PJ, Lovato R, Mancero T, Rivera J, Proaño R, et al. Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection. BMC Med. 2007;5:1–10.

56.

Katabarwa M, Eyamba A, Habomugisha P, Lakwo T, Ekobo S, Kamgno J, et al. After a decade of annual dose mass i1. Katabarwa M, Eyamba a, Habomugisha P, Lakwo T, Ekobo S, Kamgno J, et al. after a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues. Trop med Int heal. 2008; Trop Med Int Heal 2008;13:1196–203.

57.

Katabarwa MN, Eyamba A, Nwane P, Enyong P, Yaya S, Baldiagai J, et al. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in north region, Cameroon. Am J Trop Med Hyg. 2011;85:1041–9.PubMedPubMedCentral

58.

Katabarwa MN, Eyamba A, Nwane P, Enyong P, Kamgno J, Kueté T, et al. Fifteen years of annual mass treatment of onchocerciasis with ivermectin have not interrupted transmission in the west region of Cameroon. J Parasitol Res. 2013;2013:1–12.

59.

Wanji S, Kengne-Ouafo JA, Esum ME, Chounna PWN, Tendongfor N, Adzemye BF, et al. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of south West Cameroon after a decade of ivermectin treatment. Parasit Vectors. 2015;8:1–21.

60.

Kamga GR, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Mbigha-Ghogomu S, Souopgui J, et al. Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment. Parasit Vectors. 2016;9:1–12.

61.

Kamga GR, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Ghogomu SM, Souopgui J, et al. Important progress towards elimination of onchocerciasis in the west region of Cameroon. Parasit Vectors. 2017;10:1–12.

62.

Otabil KB, Gyasi SF, Awuah E, Obeng-Ofori D, Atta-Nyarko RJ, Andoh D, et al. Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin. BMC Infect Dis. 2019;19:1–7.

63.

Borsboom GJ, Boatin BA, Nagelkerke NJ, Agoua H, Akpoboua KL, Alley EW, et al. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Filaria J. 2003;2:1–25.

64.

Lamberton PH, Cheke RA, Winskill P, Tirados I, Walker M, Osei-Atweneboana MY, et al. Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors. PLoS Negl Trop Dis. 2015;9:e0003688.PubMedPubMedCentral

65.

Wanji S, Kengne-Ouafo JA, Esum ME, Chounna PWN, Adzemye BF, Eyong JEE, et al. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon. Parasit Vectors. 2015;8:1–16.

66.

Boussinesq M, Prod’hon J, Chippaux JP. Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments. Trans R Soc Trop Med Hyg. 1997;91:82–6.PubMed

67.

Pion SDS, Clément MCA, Boussinesq M, Clement MC, Boussinesq M. Impact of four years of large-scale ivermectin treatment with low therapeutic coverage on the transmission of Onchocerca volvulus in the Mbam valley focus, Central Cameroon. Trans R Soc Trop Med Hyg. 2004;98:520–8.PubMed

68.

Garms R, Walsh JF, Davies JB. Studies on the reinvasion of the Onchocerciasis control Programme in the Volta River basin by Simulium damnosum sl with emphasis on the south-western areas. Tropenmed Parasitol. 1979;30:345–62.PubMed

69.

Baker RH, Guillet P, Seketeli A, Poudiougo P, Boakye D, Wilson MD. Progress in controlling the reinvasion of windborne vectors into the western area of the Onchocerciasis control Programme in West Africa. Philos Trans R Soc L B. 1990;328:731–50.

70.

Rodriguez-Perez MA, Rodriguez MH, Margeli-Perez HM, Rivas-Alcala AR. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico. Am J Trop Med Hyg. 1995;52:429–34.PubMed

71.

Komlan K, Vossberg PS, Gantin RG, Solim T, Korbmacher F, Banla M. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and Central Togo after decades of Simulium damnosum sl vector control and mass drug administration of ivermectin. PLoS Negl Trop Dis. 2018;12:e0006312.PubMedPubMedCentral

72.

Koroma JB, Sesay S, Conteh A, Koudou B, Paye J, Bah M, et al. Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone. Infect Dis Poverty. 2018;7:1–12.

73.

Osei-Atweneboana MY, Eng JKL, Boakye DA, Gyapong JO, Prichard RK. Prevalence and intensity of Onchocerca volvulus infection and effi cacy of ivermectin in endemic communities in Ghana : a two-phase epidemiological study. Lancet. 2021:2021–9.

74.

Nana-Djeunga HC, Bourguinat C, Pion SD, Bopda J, Kengne-Ouafo JA, Njiokou F. Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naive and a frequently treated population from Cameroon. PLoS Negl Trop Dis. 2014;8:e2824.PubMedPubMedCentral

75.

Winnen M, Plaisier AP, Alley ES, Nagelkerke NJD, Van Oortmarssen G, Boatin BA, et al. Can ivermectin mass treatments eliminate onchocerciasis in Africa ? Bull World Health Organ. 2002;80:384–90.PubMedPubMedCentral

76.

Turner HC, Walker M, Churcher TS, Basáñez MG. Modelling the impact of ivermectin on river blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections. Parasit Vectors. 2014;7:1–15.

77.

Colebunders R, Basáñez MG, Siling K, Post RJ, Rotsaert A, Mmbando B. From river blindness control to elimination: bridge over troubled water. Infect Dis Poverty. 2018;7:1–15.

78.

Samuel A, Belay T, Yehalaw D, Taha M, Zemene E, Zeynudin A. Impact of six years community directed treatment with ivermectin in the control of Onchocerciasis, western Ethiopia. PLoS One. 2016;11:1–9.

79.

Opara KN, Fagbemi BO, Atting IA, Oyene UE, Okenu DMN. Status of forest onchocerciasis in the lower Cross River basin, Nigeria: change in clinical and parasitological indices after 6 years of ivermectin intervention. Public Health. 2007;121:202–7.PubMed

80.

Emukah EC, Osuoha E, Miri ES, Onyenama J, Amazigo U, Obijuru C, et al. A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo state, Nigeria. Am J Trop Med Hyg. 2004;70:556–61.PubMed

81.

Whitworth JA, Morgan D, Maude GH, Luty AJ, Taylor DW. A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to four doses given at six-monthly intervals. Trans R Soc Trop Med Hyg. 1992;86:277–80.PubMed

82.

Thiele EA, Cama VA, Lakwo T, Mekasha S, Abanyie F, Sleshi M, et al. Detection of Onchocerca volvulus in skin snips by microscopy and real-time polymerase chain reaction: implications for monitoring and evaluation activities. Am J Trop Med Hyg. 2016;94:906–11.PubMedPubMedCentral

83.

Lloyd MM, Gilbert R, Taha NT, Weil GJ, Meite A, Kouakou IM, et al. Conventional parasitology and DNA-based diagnostic methods for onchocerciasis elimination programmes. Acta Trop. 2015;146:114–8.PubMed

Title: Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia
Authors: Gebremedhin Gebrezgabiher
Zeleke Mekonnen
Delenasaw Yewhalaw
Asrat Hailu
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: River Blindness
Ivermectin
Published in: BMC Public Health / Issue 1/2020
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-020-09344-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

The protective effect of alcohol consumption on the incidence of cardiovascular diseases: is it real? A systematic review and meta-analysis of studies conducted in community settings

A sex education program for teachers of preschool children: a quasi-experimental study in Iran

Health effects of heating, ventilation and air conditioning on hospital patients: a scoping review

Mediating role of coping style on the relationship between job stress and subjective well-being among Korean police officers

The relationship between screen-based sedentary behaviors and symptoms of depression and anxiety in youth: a systematic review of moderating variables

The cascade of care in managing hypertension in the Arab world: a systematic assessment of the evidence on awareness, treatment and control